Literatura académica sobre el tema "Mesoporous bioactive glasse"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Mesoporous bioactive glasse".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Mesoporous bioactive glasse"
Migneco, Carla, Elisa Fiume, Enrica Verné y Francesco Baino. "A Guided Walk through the World of Mesoporous Bioactive Glasses (MBGs): Fundamentals, Processing, and Applications". Nanomaterials 10, n.º 12 (21 de diciembre de 2020): 2571. http://dx.doi.org/10.3390/nano10122571.
Texto completoZhao, Yu Feng y Jan Ma. "Mesoporous Bioactive Glasses: Synthesis, Characterization and In Vitro Bioactivity". Journal of Biomimetics, Biomaterials and Tissue Engineering 1 (julio de 2008): 37–47. http://dx.doi.org/10.4028/www.scientific.net/jbbte.1.37.
Texto completoPhetnin, Ratiya y Sirirat Tubsungnoen Rattanachan. "Bio-Hybrid Composite Scaffold from Silk Fibroin/Chitosan/Mesoporous Bioactive Glass Microspheres for Tissue Engineering Applications". Advanced Materials Research 1131 (diciembre de 2015): 79–83. http://dx.doi.org/10.4028/www.scientific.net/amr.1131.79.
Texto completoLiu, Jiawei, Guo Du, Hongda Yu, Xueyin Zhang y Tiehong Chen. "Synthesis of Hierarchically Porous Bioactive Glass and Its Mineralization Activity". Molecules 28, n.º 5 (27 de febrero de 2023): 2224. http://dx.doi.org/10.3390/molecules28052224.
Texto completoMuhammad Ikram, Shabbir Hussain y Mohsin Javed. "Nature and Therapeutic Potential of Silica-based Mesoporous Bioactive Glass". Scientific Inquiry and Review 3, n.º 2 (5 de junio de 2019): 17–26. http://dx.doi.org/10.32350/sir.32.03.
Texto completoKermani, Farzad, Hossein Sadidi, Ali Ahmadabadi, Seyed Javad Hoseini, Seyed Hasan Tavousi, Alireza Rezapanah, Simin Nazarnezhad, Seyede Atefe Hosseini, Sahar Mollazadeh y Saeid Kargozar. "Modified Sol–Gel Synthesis of Mesoporous Borate Bioactive Glasses for Potential Use in Wound Healing". Bioengineering 9, n.º 9 (5 de septiembre de 2022): 442. http://dx.doi.org/10.3390/bioengineering9090442.
Texto completoSon, Sung-Ae, Dong-Hyun Kim, Kyung-Hyeon Yoo, Seog-Young Yoon y Yong-Il Kim. "Mesoporous Bioactive Glass Combined with Graphene Oxide Quantum Dot as a New Material for a New Treatment Option for Dentin Hypersensitivity". Nanomaterials 10, n.º 4 (27 de marzo de 2020): 621. http://dx.doi.org/10.3390/nano10040621.
Texto completoSalinas, Antonio J. y Maria Vallet-Regí. "The Sol–Gel Production of Bioceramics". Key Engineering Materials 391 (octubre de 2008): 141–58. http://dx.doi.org/10.4028/www.scientific.net/kem.391.141.
Texto completoSchmitz, Seray, Ana M. Beltrán, Mark Cresswell y Aldo R. Boccaccini. "A Structural Comparison of Ordered and Non-Ordered Ion Doped Silicate Bioactive Glasses". Materials 13, n.º 4 (22 de febrero de 2020): 992. http://dx.doi.org/10.3390/ma13040992.
Texto completoSalinas, Antonio J. y Pedro Esbrit. "Mesoporous Bioglasses Enriched with Bioactive Agents for Bone Repair, with a Special Highlight of María Vallet-Regí’s Contribution". Pharmaceutics 14, n.º 1 (15 de enero de 2022): 202. http://dx.doi.org/10.3390/pharmaceutics14010202.
Texto completoTesis sobre el tema "Mesoporous bioactive glasse"
Yuen, Jones. "Preparation, characterisation and in vivo osteogenesis of mesoporous bioactive glasses". Thesis, Queensland University of Technology, 2012. https://eprints.qut.edu.au/53101/1/Jones_Yuen_Thesis.pdf.
Texto completoFan, J. P. "Mesoporous bioactive glass and alginate composite scaffolds for tissue engineering". Thesis, University College London (University of London), 2014. http://discovery.ucl.ac.uk/1443622/.
Texto completoFernando, Jesu Delihta Liyaa. "Novel Mesoporous Bioactive Glasses (MBGs) as fillers in dental adhesives « Synthesis, Physico-chemical and biological evaluation »". Thesis, Lyon, 2018. http://www.theses.fr/2018LYSE1072/document.
Texto completoImproving the stability of adhesive dentin interface is crucial to extend the longevity of composite restorations. Remineralization through use of ion releasing materials is a promising approach to protect the hybrid layer from hydrolytic and enzymatic degradation. Mesoporous bioactive glasses (MBGs) offer attractive surface features (enhanced surface area and porosity) to use them as fillers in dental adhesives to promote remineralization through ions release. Moreover, the functionalization of pores with antibacterial drugs is a good way to combat secondary caries. The present work focused on the synthesis and evaluation of novel MBGs suitable to be used as fillers in dental adhesives. The MBGs were prepared in an acetate based sol-gel system with industrially safe and non-toxic precursors. MBGs prepared in large scale (50g) offered enhanced surface characteristics in comparison to small scale (10g) MBGs. The investigation on the influence of network modifiers (CaO:Na2O) on the surface characteristics of MBGs revealed that the porosity was driven by CaO content in the composition. Notable, very high surface area (535m2g-1) and pore volume (0.33cm3g-1) was attained in the MBG with highest CaO content. Next, the order of precursor addition effect on the surface characteristics of MBGs has been studied. By Keeping the composition fixed and varying the order of precursor addition during sol-gel synthesis a doubling of surface area, 1.5 times increase in pore volume and 1.2 times decrease in mean pore size was obtained. The demonstrated method is a simple and straightforward route to improve the porosity and homogeneity of MBGs. Furthermore, modulation of mean pore size for a fixed composition is also useful to tailor the pores of the fillers for drug delivery application. With regards to bioactivity, the MBG fillers with highest CaO content had increased calcium phosphate precipitate in SBF after 7 days as opposed to MBG with high Na2O content. Furthermore, all tested samples were non-cytotoxic to Human Gingival Fibroblasts (HGFs) in vitro. Positively, MBGs treated at lower temperature significantly enhanced the metabolic activity of HGFs. Ball milling was employed to reduce the primary particle size of MBG to less than 3μm. Milling seemingly had an adverse effect on the porosity of the MBG filler. Nevertheless, some porosity remained. The commercial adhesive was mixed with 3, 10, 20 and 30 weight percentage of MBG filler. MBG filled adhesive up to10 weight percent filler content had flowable viscosity suitable for adhesive application. The developed MBG with high porosity and CaO content appears as a new step in the development of dental adhesives and also other bioactive dental materials
Yu, Jing-Lun y 余境倫. "Preparation and characterization of mesoporous bioactive glass fibrous microspheres". Thesis, 2015. http://ndltd.ncl.edu.tw/handle/a89yuw.
Texto completo翁如春. "Preparation and characterization of mesoporous bioactive glass nanofibrous matrix". Thesis, 2013. http://ndltd.ncl.edu.tw/handle/99640272113840962284.
Texto completoLin, Yi-Hsuan y 林奕萱. "Preparation of mesoporous bioactive glass/polycaprolactone nanofibrous matrix and the effect of mesoporous bioactive glass on the characteristics of MG63 osteoblast-like cells". Thesis, 2011. http://ndltd.ncl.edu.tw/handle/70014453684660642454.
Texto completo國立臺灣海洋大學
生物科技研究所
99
Polycaprolactone (PCL) is a biodegradable polymer, and it has recently attracted much interest because of its cost efficiency and high toughness as bone tissue engineering scaffold. However, it lacks hydrophilicity and bioactivity. Mesoporous bioactive glass (MBG) has been used for bone tissue engineering due to their reported superior bone-forming bioactivity. The electrospinning technique is a convenient method for production of ultra-thin fibers with diameters ranging from submicrons to a few nanometers. In this study, we utilized an electrospinning fabrication process for the production of nanofibrous matrix that is composed of PCL and MBG. The mean diameter of the composite nanofibrous matrix was approximately 300 nm, this dimension is similar to that of native fibrous protein within the extracellular matrix (ECM). Moreover, we explored the effects of MBG on the hydrophilicity, mechanical strength, bioactivity and cellular response. From the data, MBG/PCL nanofiberous matrix exhibited a significantly improved surface hydrophilicity compared to PCL nanofibrous matrix. The bone-forming bioactivity of matrix was evaluated by soaking the matrix in a simulated body fluid. We could find the MBG/PCL nanofibrous matrix induced a layer of hydroxyapatite in a simulated body fluid at 7 days. The hydroxyapatite crystals were similar in composition to human bone mineral via SEM, X-ray diffraction, EDX analysis and ATR-FTIR. Finally, The cellular attachment rate, proliferation, differentiation and mineralization activity of MG63 osteoblast-like cells were significantly higher for MBG/PCL nanofibrous matrix than for PCL nanofibrous matrix. In addition, with regard to the osteoblast gene and protein ability, we observed that Real-time PCR and western blotting of MG63 cells on the MBG/PCL nanofibrous matrix higher than on the PCL nanofibrous matrix. This indicated that MBG/PCL nanofibrous matrix could potentially be used as a bone graft for bone regeneration.
Kusriantoko, Parindra y Parindra Kusriantoko. "Degradation behavior and bioactivity of various compositional mesoporous bioactive glasses". Thesis, 2015. http://ndltd.ncl.edu.tw/handle/60632792522965831264.
Texto completo國立臺灣科技大學
材料科學與工程系
103
Spray pyrolysis has been successfully used to synthesize mesoporous bioactive glasses (MBGs) with different compositions of SiO2-CaO-P2O5. In this study, the degradability and bioactivity of 58S, 68S and 76S MBG samples were studied. Simulated body fluid (SBF) solution was used as a medium to conduct the degradation test and also bioactivity for 30 days. The weight loss of MBG bulks were measured every day during the in-vitro degradation test. The pH value changes in SBF solution was also monitored every day in order to know the reaction that may occur in SBF solution. Some characterization methods, including x-ray diffraction analysis (XRD), fourier transform infrared (FTIR), scanning electron microscopy (SEM) and energy dispersive spectroscopy (EDS) have been used to know the phase changes, chemical bonding, surface morphology and compositional analysis respectively. In this research, the effect of composition on the degradation behavior and bioactivity were discussed. Since the degradation behavior of MBG was correlated to the apatite conversion. Furthermore, the mechanism of biodegradability on MBG to apatite conversion was also investigated. 58S MBG had the high degradation rate followed by 68S and 76S respectively. 68S and 76S MBG had ability to form apatite phase with 1 day of immersion while 58S MBG required 3 days of immersion.
Lu, Pei-Shan y 呂沛珊. "Bone-regenerative Mesoporous Bioactive Glasses Scaffold with Drug Controlled Release". Thesis, 2011. http://ndltd.ncl.edu.tw/handle/09616899695926131384.
Texto completo高雄醫學大學
香粧品學系碩士班
99
Mesoporous bioactive glasses scaffold (MBGs) possess a high specific surface area, and exhibits macropores (about 200−400 μm) and mesopores (2-50 nm) structures. Pore wall functionalized and enhancing bone-regenerative ability are the other advantages of MBGs. For these reasons, MBGs is considered to be a candidate for two main uses, bone tissue engineering and drug controlled delivery system. The purpose of this study is to confirm bioactivity of MBGs by in vitro tests and also as a gentamicin carrier to control drug release. MBGs had been constructed by N2 adsorption/desorption and transmission electron microscope exhibits… a large specific surface area ( 328 m2/g ), pore volume ( 0.71 cm3/g ) and a uniformly distributed pore size ( 7.3 nm ), For comparison, in vitro tests results strongly suggest that MBGs is noncytotoxic, better cell affinity than non-mesoporous bioactive glasses scaffold (BGs) and can help cells division and differentiation. The loading content and drug loading efficiency of MBGs are significant than BGs, and the values are 19.2 mg/g and 31.1%. It also been suggested the release rate of MBGs is much slower than BGs. Loading efficiency and content are depends of of initial concentration. The largest amount of drug adsorption was 39.9 mg/g. The release curve exhibits a two- step release behavior, and fit Higuchi model. It also indicates that gentamicin burst-releases initially for a duration of 24 hrs, and then constantly slows released.
Chen, Yi-Jhen y 陳儀蓁. "Synthesis and antibacterial evaluations of silver-incorporated mesoporous bioactive glass". Thesis, 2013. http://ndltd.ncl.edu.tw/handle/96371637959720874960.
Texto completo高雄醫學大學
香粧品學系碩士班
101
Root canal therapy is an important procedure in endodontic treatment. The current temporary dressing, calcium hydroxide, may fail to eliminate certain facultative bacteria found in the system, which might cause treatment failure. In this study, we synthesis silver-incorporated mesoporous bioactive glass (MBG-Ag). Hoping to combine the biocompatibility and bioactive of bioactive glass and releasable silver ion. Nitrogen Adsorption/Desorption Isotherm, Transmission Electron Microscopy, Scanning Electron Microscopy, X-ray Diffraction and Fourier transform infrared spectroscopy are used to analyze MBG-Ag. The results indicate that incorporating high content of silver will tend to form ball-shape particles, and the mesopore structure (6-7 nm) won’t be affected. The time-dependent and content-dependent antibacterial activity of MBG-Ag is evaluated by using E. coli. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) is 0.75 mg/ml and 1 mg/ml for E. coli, 0.5 mg/ml and 2.5 mg/ml for E. faecalis, respectively. And for the golden standard of temporary dressing, calcium hydroxide, the MIC against E. faecalis is 5 mg/ml. The silver in MBG-Ag is releasable and causing the antibacterial activity after one hour exposure.
Hong, Bo-Jiang y 洪柏江. "Surfactant-free synthesis of mesoporous bioactive glass for drug delivery". Thesis, 2018. http://ndltd.ncl.edu.tw/handle/9mj829.
Texto completo國立臺灣科技大學
材料科學與工程系
106
The occurrence of the open fractures is often accompanied by complex treatment procedures. In the early stages of treatment for the open fracture, antibiotics are often required to prevent the risk of infection. In addition, in order to achieve an effective therapeutic effect, antibiotics require regular quantitative implantation for the human body. The application of the drug carrier can effectively control the release of the drug and also reduce the number of times to implant the drug into the human body. In the bone fractures of the elderly, the skeletal reparability of the elderly is relatively poor. Bioactive glass is a potential biomaterial for bone implants and drug carriers because it has excellent bioactivity and forms a hydroxyl apatite (HA) layer when immersed in body fluid. In the research of drug carriers, increasing the specific surface area and pore volume can effectively affect the drug loading of the material. One product of these studies is mesoporous bioactive glass (MBG), which has a high specific surface. The common pore-forming agents of MBG are surfactants; however, surfactants present the serious problems of micelle aggregation and carbon contamination. To overcome these problems, hydrogen peroxide (H2O2) has been used as a pore-forming agent to replace the traditional surfactants, such as P123, and F127. In this study, 0, 25, 40, 50, and 69 vol% H2O2-treated MBG powders were synthesized using spray pyrolysis (SP). The corresponding formation mechanisms are also discussed. The results shows that samples with high specific surface area and high pore size have higher drug release.
Capítulos de libros sobre el tema "Mesoporous bioactive glasse"
Branda, F. "Synthesis and Functionalization of Mesoporous Bioactive Glasses for Drug Delivery". En Clinical Applications of Biomaterials, 257–86. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-56059-5_7.
Texto completoVerné, Enrica, Francesco Baino, Marta Miola, Giorgia Novajra, Renato Mortera, Barbara Onida y Chiara Vitale-Brovarone. "Bioactive Glass-Ceramic/Mesoporous Silica Composite Scaffolds for Bone Grafting and Drug Release". En Ceramic Transactions Series, 123–29. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2010. http://dx.doi.org/10.1002/9780470909812.ch14.
Texto completoLu, P. S., L. C. Chiou, I. L. Chang, C. J. Shih y L. F. Huang. "The Influences of the Heat-Treated Temperature on Mesoporous Bioactive Gel Glasses Scaffold in the CaO — SiO2 — P2O5 System". En IFMBE Proceedings, 1362–65. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-92841-6_336.
Texto completoGupta, N. y D. Santhiya. "Mesoporous bioactive glass and its applications". En Bioactive Glasses, 63–85. Elsevier, 2018. http://dx.doi.org/10.1016/b978-0-08-100936-9.00003-4.
Texto completoBin Zafar Auniq, Reedwan, Namon Hirun y Upsorn Boonyang. "Three-Dimensionally Ordered Macroporous-Mesoporous Bioactive Glass Ceramics for Drug Delivery Capacity and Evaluation of Drug Release". En Ceramic Materials [Working Title]. IntechOpen, 2020. http://dx.doi.org/10.5772/intechopen.95290.
Texto completoGómez-Cerezo, N., D. Arcos y M. Vallet-Regí. "Mesoporous bioactive glasses for biomedical composites". En Materials for Biomedical Engineering, 355–91. Elsevier, 2019. http://dx.doi.org/10.1016/b978-0-12-818431-8.00011-8.
Texto completoHum, Jasmin, Anahí Philippart, Elena Boccardi y Aldo R. Boccaccini. "Mesoporous Bioactive Glass-Based Controlled Release Systems". En Inorganic Controlled Release Technology, 139–59. Elsevier, 2016. http://dx.doi.org/10.1016/b978-0-08-099991-3.00005-3.
Texto completoGuo, Ya-Ping, Jun-ying Lü y Qin-Fei Ke. "Mesoporous Bioactive Glasses: Fabrication, Structure, Drug Delivery Property, and Therapeutic Potential". En Biomedical, Therapeutic and Clinical Applications of Bioactive Glasses, 127–51. Elsevier, 2019. http://dx.doi.org/10.1016/b978-0-08-102196-5.00004-5.
Texto completoFiume, Elisa y Francesco Baino. "Robocasting of mesoporous bioactive glasses (MBGs) for bone tissue engineering". En Bioceramics, 327–49. Elsevier, 2021. http://dx.doi.org/10.1016/b978-0-08-102999-2.00014-4.
Texto completoWu, Chengtie, Jiang Chang y Yin Xiao. "Mesoporous Bioactive Glasses for Drug Delivery and Bone Tissue Regeneration". En Advanced Bioactive Inorganic Materials for Bone Regeneration and Drug Delivery, 1–24. CRC Press, 2013. http://dx.doi.org/10.1201/b13926-2.
Texto completoActas de conferencias sobre el tema "Mesoporous bioactive glasse"
Frent, Corina, Ioana Rusu y Adriana Vulpoi-Lazar. "Ceria containing mesoporous bioactive glasses with positive biological functionalities". En RAD Conference. RAD Centre, 2022. http://dx.doi.org/10.21175/rad.sum.abstr.book.2022.2.2.
Texto completo